MAKO Key Stats
- One Way MAKO Surgical Could Quadruple Fool May 22
- MAKO Surgical Notches Another Legal Victory Fool May 20
- The Best- And Worst- Performing Biotech Stocks, May 10 To May 17 May 19
- MAKO SURGICAL CORP. Financials May 15
- This High-Growth Health Care Stock's Troubles Continue May 13
- 5 Healthcare Stock Earnings Snapshots May 12
- 5 of Last Week's Biggest Winners May 12
- Will MAKO Surgical Reach Profitability Before 2015? May 9
- MAKO Surgical: Burden Of Proof Still On Management May 9
- Analysts: Discovery Sales Will Increase and 2 Other Research Notes to Check Out May 8
MAKO Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). MAKO Surgical Corporation is down 52.64% over the last year vs S&P 500 Total Return up 27.81%, Intuitive Surgical down 5.71%, and ArthroCare Corporation up 35.29%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for MAKO
Pro Report PDF for MAKO
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download MAKO Pro Report PDF
Pro Strategies Featuring MAKO
Did MAKO Surgical Corporation make it into our Pro Portfolio Strategies?
Founded in 2004, MAKO Surgical Corp. is an innovative medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic System and proprietary RESTORIS® family of implants to surgeons for a procedure called MAKOplasty® that provides a less invasive method for knee resurfacing and a new procedure for Total Hip Arthroplasty. MAKOplasty® is powered by the RIO® Robotic Arm Interactive Orthopedic System, a highly advanced robotic arm technology that assists your orthopedic surgeon in achieving consistently reproducible precision for the individual patient in knee and hip joint replacement. MAKOplasty® Partial Knee Resurfacing is an innovative treatment option designed to relieve pain and restore range of motion for adults living with early to mid-stage osteoarthritis that has not progressed to all three compartments of the knee. MAKOplasty® Total Hip Arthroplasty, is a new RIO® robotic arm application for those in need of total hip replacement. Advanced robotic arm technology and versatile implants assist surgeons in attaining a new level of accuracy and precision designed to restore mobility and active lifestyle. The company markets its products through direct sales force, as well as through independent orthopedic product agents and distributors. MAKO Surgical Corp. was founded in November 2004 and is headquartered in Fort Lauderdale, Florida.